Invention Grant
- Patent Title: Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen
- Patent Title (中): 用诺卡非芬自身保护眼用配方治疗干眼症的方法
-
Application No.: US12622509Application Date: 2009-11-20
-
Publication No.: US08765787B2Publication Date: 2014-07-01
- Inventor: A.K. Gunnar Aberg , Keith Johnson
- Applicant: A.K. Gunnar Aberg , Keith Johnson
- Applicant Address: US FL Sarasota
- Assignee: Bridge Pharma, Inc.
- Current Assignee: Bridge Pharma, Inc.
- Current Assignee Address: US FL Sarasota
- Agency: Cantor Colburn LLP
- Main IPC: A61K31/4535
- IPC: A61K31/4535
Abstract:
Self-preserving ophthalmic formulations containing norketotifen and methods of making the same and the use thereof in patients suffering from xerophthalmia are disclosed. The methods also comprise administering to the eyes of a mammal in need thereof, self-preserving topical ophthalmic formulations containing norketotifen, free from any added preservative.
Public/Granted literature
- US20100130550A1 OCULAR FORMULATIONS OF NORKETOTIFEN Public/Granted day:2010-05-27
Information query
IPC分类:
